Catatoniaa propósito de un caso

  1. Olazabal Eizaguirre, Nora
  2. Bustamante Madariaga, Sonia
  3. Solano Iturri, Goizalde
  4. Rahmani, Reda
  5. Erkoreka González, Leire
  6. González Torres, Miguel Ángel
Journal:
Revista de la Asociación Española de Neuropsiquiatría

ISSN: 0211-5735

Year of publication: 2011

Volume: 31

Issue: 109

Pages: 111-119

Type: Article

DOI: 10.4321/S0211-57352011000100008 DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Revista de la Asociación Española de Neuropsiquiatría

Abstract

We present a clinical picture of mutism, akinesia and stupor with fever and urinary retention in a 65-year-old woman, as an example of catatonia. The catatonic symptomatology has been established as a syndrome which can have multiple etiologies, both medical and psychiatric. Beside that, pharmacological, toxic and organic precipitant factors have been described. Therefore a multidisciplinary approach is required to make more precise the etiological diagnosis. Many authors point out that this syndrome is underdiagnosed. During the assessment, diagnosis and treatment of this patient, we found that there is lack of clear and updated diagnostic criteria, as well as evidence-based treatment algorithms. Benzodiazepines and ECT are first line treatments, along with supportive care and prevention of complications. Other non-protocolized strategies have been published as an alternative in refractory cases.

Bibliographic References

  • (1) KAHLBAUM K. Die Katatonie oder das Spannungsirresein. Eine klinische Form psychischer Krankheit. Berlin. Germany: Hirschwald, 1874.
  • (2) KRAEPELIN E. Einfiihnmg in die psychiatrische Klinik. Vol. 3. Auflage. Leipzig, Germany: Barth, 1916.
  • (3) BLEULER E. Dementia praecox oder Gruppe der Schizophrenien.Vol. I. Auflage. Leipzig, Germany: Deuticke, 1911.
  • (4) WEDER ND, MURALEE S, PENLAND H,TAMPI RR. Catatonia: A Review. Ann Clin Psychiatry. 2008;20:97-107
  • (5) FINK M., TAYLOR MA. Catatonia: A clinician’s guide to diagnosis and Treatment. Cambridge: Cambridge University Press, 2003
  • (6) PERALTA V, CUESTA MJ. Motor features in psychotic disorders. 2. Development of diagnostic criteria for catatonia. Schizophr Res 2001; 47:117-26.
  • (7) NORTHOFF G, KOCK A, WENKE J, ECKERT J, BOKER H, PFLUG B, BOGERTS B. Catatonia as a psychomotor syndrome: a rating scale and extrapyramidal motor symptoms. Mov Disord 1999; 14:404–16.
  • (8) ARIAS M, PÁRAMO M, REQUENA ISESAR AROBELO MPELETEIRO M La catatonía maligna como paradigma de enfermedad neuropsiquiátrica. Neurología 2003; 18: 107-11.
  • (9) AHUJA N. Organic catatonia: a review. Ind J Psychiatry 2000; 42: 327-46.
  • (10) AKHTAR, S. AHMAD, H. Ciprofloxacin-induced catatonia. J ClinPsychiatry 1993; 54:115–6.
  • (11)Fink M. Neuroleptic malignant syndrome and catatonia: one entity or two? Biol Psychiatry 1996; 39:1–4.
  • (12) CARROLL BT, TAYLOR BE. The nondichotomy between lethal catatonia and neuroleptic malignant syndrome. J Clin Psychopharmacol 1997; 17:235–6.
  • (13) FINK M. Toxic serotonin syndrome or neuroleptic malignant syndrome? Case report. Pharmacopsychiatry 1996; 29:159–61.
  • (14) CARROLL BT, GRAHAM KT, THALASSINOS AJ: A common pathogenesis of the serotonin syndrome, catatonia, and neuroleptic malignant syndrome. J Neuropsychiatry Clin Neurosci 2001; 13:150.
  • (15) FINK M, TAYLOR MA, The Catatonia Syndrome. Forgotten but Not Gone. Arch Gen Psychiatry 2009; 66:1173-7.
  • (16) ROSEBUSH PI, HILDEBRAND AM, FURLONG BG, MAZUREK MF. Catatonic syndrome in a general psychiatric in-patient population: frecuency, clinical presentation and reponse to lorazepam. J Clin Psychiatry 1990; 51:357-62.
  • (17) VAN DER HEIJDEN F M, TUINIER S, ARTS NJ, HOOGENDOORN ML, KAHNS RS, VERHOEVEN WM. Catatonia: disappeared or under-diagnosed? Psychopathology 2005; 38:3–8.
  • (18) TAYLOR MA, ABRAMS R. Catatonia: prevalence and importance in the manic phase of manicdepressive illness. Arch Gen Psychiatry 1977; 34:1223–5.
  • (19) AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and Statistical Manual of Mental Disorders, Fourth edition (DSM–IV). Arlington, VA: American Psychiatric Publishing, 1994.
  • (20) TAYLOR M A, FINK M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 2003; 160:1233–41.
  • (21) ROSEBUSH PI, MAZUREK MF. Catatonia and its treatment. Schizophr Bull 2010; 36:239-42.
  • (22) FRICCHIONE GL, CASSEM NH, HOOBERMAN D, HOBSON D: Intravenous lorazepam in neuroleptic-induced catatonia. J Clin Psychopharmacol 1983; 3:338–42.
  • (23) TROLLOR JN, SACHDEV PS: Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases. Aust N Z J Psychiatry 1999; 33:650–9.
  • (24) BUSH G, FINK M, PETRIDES G, DOWLING F, FRANCIS A. Catatonia, II: treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 1996; 93:137–43.
Data source: Dialnet